Artículos por temáticas

The Transition from Standing to Walking Is Affected in People with Parkinson's Disease and Freezing of Gait

Amundsen Huffmaster SL, Lu C, Tuite PJ, MacKinnon CD.

J Parkinsons Dis. 2020;10(1):233-243. doi: 10.3233/JPD-191649.

Identification of Biomolecular Information in Rotenone-Induced Cellular Model of Parkinson's Disease by Public Microarray Data Analysis

Yu F, Le ZS, Chen LH, Qian H, Yu B, Chen WH.

J Comput Biol. 2020 Jun;27(6):888-903. doi: 10.1089/cmb.2019.0151. Epub 2019 Oct 9.

Differential proteomic analysis of serum exosomes reveals alterations in progression of Parkinson disease.

Jiang R, Rong C, Ke R, Meng S, Yan X, Ke H, Wu S.

Medicine (Baltimore). 2019 Oct;98(41):e17478. doi: 10.1097/MD.0000000000017478.

The Influence of Body Mass Index at Diagnosis on Cognitive Decline in Parkinson's Disease.

Yoo HS, Chung SJ, Lee PH, Sohn YH, Kang SY.

J Clin Neurol. 2019 Oct;15(4):517-526. doi: 10.3988/jcn.2019.15.4.517.

Combined Assessment of Serum Alpha-Synuclein and Rab35 is a Better Biomarker for Parkinson's Disease.

Wang HL, Lu CS, Yeh TH, Shen YM, Weng YH, Huang YZ, Chen RS, Liu YC, Cheng YC, Chang HC, Chen YL, Chen YJ, Lin YW, Hsu CC, Lin HL, Chiu CH, Chiu CC.

J Clin Neurol. 2019 Oct;15(4):488-495. doi: 10.3988/jcn.2019.15.4.488.

Backward Gait is Associated with Motor Symptoms and Fear of Falling in Patients with De Novo Parkinson's Disease.

Kwon KY, Park S, Lee HM, Park YM, Kim J, Kim J, Koh SB.

J Clin Neurol. 2019 Oct;15(4):473-479. doi: 10.3988/jcn.2019.15.4.473.

The necroptosis machinery mediates axonal degeneration in a model of Parkinson disease

Oñate M, Catenaccio A, Salvadores N, Saquel C, Martinez A, Moreno-Gonzalez I, Gamez N, Soto P, Soto C, Hetz C, Court FA.

Cell Death Differ. 2020 Apr;27(4):1169-1185. doi: 10.1038/s41418-019-0408-4. Epub 2019 Oct 7.

Serotonergic innervation of the striatum in a nonhuman primate model of Parkinson's disease

Jiménez-Sánchez L, Blesa J, Del Rey NL, Monje MHG, Obeso JA, Cavada C.

Neuropharmacology. 2020 Jun 15;170:107806. doi: 10.1016/j.neuropharm.2019.107806. Epub 2019 Oct 4.

Midnolin is a confirmed genetic risk factor for Parkinson's disease.

Obara Y, Sato H, Nakayama T, Kato T, Ishii K.

Ann Clin Transl Neurol. 2019 Oct 6. doi: 10.1002/acn3.50914. [Epub ahead of print]

Apelin-36 mediates neuroprotective effects by regulating oxidative stress, autophagy and apoptosis in MPTP-induced Parkinson's disease model mice

Zhu J, Gao W, Shan X, Wang C, Wang H, Shao Z, Dou S, Jiang Y, Wang C, Cheng B.

Brain Res. 2020 Jan 1;1726:146493. doi: 10.1016/j.brainres.2019.146493. Epub 2019 Oct 3.

Neural bases of impulse control disorders in Parkinson's disease: A systematic review and an ALE meta-analysis.

Santangelo G, Raimo S, Cropano M, Vitale C, Barone P, Trojano L.

Neurosci Biobehav Rev. 2019 Oct 3;107:672-685. doi: 10.1016/j.neubiorev.2019.09.041. [Epub ahead of print] Review.

Yoga Improves Balance and Low-Back Pain, but Not Anxiety, in People with Parkinson's Disease.

Myers PS, Harrison EC, Rawson KS, Horin AP, Sutter EN, McNeely ME, Earhart GM.

Int J Yoga Therap. 2019 Oct 4. doi: 10.17761/2020-D-18-00028. [Epub ahead of print]

Association between Parkinson's Disease and Risk of Cancer: A PRISMA-compliant Meta-analysis.

Zhang P, Liu B.

ACS Chem Neurosci. 2019 Oct 16;10(10):4430-4439. doi: 10.1021/acschemneuro.9b00498. Epub 2019 Oct 4.

Association of striatal dopaminergic neuronal integrity with cognitive dysfunction and cerebral cortical metabolism in Parkinson's disease with mild cognitive impairment.

Kim H, Oh M, Oh JS, Moon H, Chung SJ, Lee CS, Kim JS.

Nucl Med Commun. 2019 Oct 2. doi: 10.1097/MNM.0000000000001098. [Epub ahead of print]

Nomenclature of Genetically Determined Myoclonus Syndromes: Recommendations of the International Parkinson and Movement Disorder Society Task Force.

van der Veen S, Zutt R, Klein C, Marras C, Berkovic SF, Caviness JN, Shibasaki H, de Koning TJ, Tijssen MAJ.

Mov Disord. 2019 Oct 4. doi: 10.1002/mds.27828. [Epub ahead of print] Review.